Session Details

A starting point for collaborative research among industry-academia-pharmaceutical researchers to control intractable diseases

Fri. Mar 29, 2024 9:45 AM - 11:45 AM JST
Fri. Mar 29, 2024 12:45 AM - 2:45 AM UTC
[Room 313] Conference Center 313+314 (3F)
Organizer: Hitoshi Tsugawa (Div. Host Defense Mechanism, Tokai Univ. Sch. Med.), Masateru Miyake (Otsuka Pharmaceutical)
Overcoming intractable diseases such as cancer, inflammatory bowel disease (IBD), and infectious diseases is a major research topic. Both industry and academia continue to conduct research aimed at establishing preventive and therapeutic methods for intractable diseases. Private enterprises is also actively engaged in applied research using clinical specimens, and researches are being conducted to elucidate the mechanisms of disease onset and to identify drug target molecules. Industry–Academia collaborative research will bring great results in translating research findings into clinical practice. In this symposium, researchers from industry and academia will discuss research results from their respective standpoints and consider the future direction of industry-academia collaboration.

[S06-1]Functional analysis of specific IgA antibodies against pathobiont associated with Crohn's disease and its clinical application

○Jin Imai1, Katsuto Hozumi1 (1. Tokai University Sch. Med.)

[S06-2]Intestinal microbiota and health: Personalized prevention based on gut microbiome data

○Natsuki Suganuma1,2 (1. bacterico Co., Ltd., 2. Keio University)

[S06-3]Functional analysis of the type III secretion system and its effectors in Bordetella

○Asaomi Kuwae1 (1. Grad Sch Infect Cont Sci, Kitasato Univ)

[S06-4]Drug discovery research support by automated electrophysiological approach

○Takayuki Oka1, Mitsuyoshi Shimane1 (1. Nanion Technologies Japan)

[S06-5]Extracellular vesicles, industry-academia collaboration, and social implementation

○Juntaro Matsuzaki1 (1. Keio University Faculty of Pharmacy)

[S06-6]The role of Kampo medicine in aging society: improvement of general medical condition

○Sachiko Mogami1 (1. TSUMURA Kampo Research Laboratories)